Opinion|Articles|December 15, 2023
Supplements and Featured Publications
- Treatment of Spinal Muscular Atrophy: Managed Care Considerations for Gene Therapy
Treatment of Spinal Muscular Atrophy: Managed Care Considerations for Gene Therapy
Advertisement
This AJMC® Clinical Brief focuses on managed care considerations for the treatment of spinal muscular atrophy.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
2
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
3
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
4
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
5









































